News

Buccolam is an oral midazolam provided in a pre-measured, age-specific dose formulation for convenient buccal (i.e. via the cavity between the cheek and gum line) delivery which is

CanAm Bioresearch is a contract research organization (CRO) engaged in pre-clinical discovery and development, particularly focused on medicinal chemistry. EpiTherapeutics R&D EVP Lars-Ole Gerlach said they are very

H-FABP, which is a low-weight cytoplasmic protein (15kDa), demonstrated high sensitivity. Study from the University of Manchester, UK, suggested that using a combination hsTnT, H-FABP and ECG on

The study aims to assess the efficacy, safety and tolerability of cenicriviroc versus the comparator regimen in 150 HIV-1-infected, patients with antiretroviral treatment-naive with only CCR5-tropic virus. In

VAC-3S is designed to fight the pathogenicity of the virus by blocking the decrease of the CD4 + T lymphocytes cell count. The VAC-3S project was supported by

Scil Technology, a company engaged in drug development, formulation and analytics, is a wholly owned subsidiary of BioNet Holding. Scil Technology CEO Christian Nafe said the grant will

A subsidiary of Japan-based global specialty pharmaceutical company Kyowa Hakko Kirin, ProStrakan aims to introduce Rectiv in the first quarter of 2012 in the US. Marketed under the

P2D Bioscience said preclinical testing and numerous scientific publications indicate that PD2007 inhibits dopamine transport in multiple brain regions. The company said, in addition to its inhibiting activity,

As part of the neuroscience therapeutic area partnership, which is now expanded to cardiovascular and metabolic diseases, Jubilant will deliver a steady stream of preclinical outcomes to AstraZeneca.